Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alper Türkel
Observed names:
A. Türkel,
ALPER TURKEL,
ALPER TÜRKEL,
Alper Turkel,
Türkel, Alper
Institutions:
Eskişehir City Hospital,
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
Observed institutions:
Eskişehir City Hospital,
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
ORCID:
0000-0001-5071-9679
Observed ORCID:
0000-0001-5071-9679
OpenAlex ID:
A5068544398
Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer
2023
·
Alper Türkel
, Cengiz Karaçin
, et al.
·
Journal of Oncology Pharmacy Practice
·
11
Vortex keratopathy associated with ribociclib
2022
·
Alper Türkel
, Sibel Özdoğan
, et al.
·
Journal of Oncology Pharmacy Practice
·
10
The mediating effect of intrusive rumination on the relationship between illness uncertainty and fear of cancer recurrence in breast cancer survivors
2025
·
Alper Türkel
, Nur Nihal Türkel
, et al.
·
BMC Women s Health
·
9
PDF
Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study
2024
·
Ebru Karci
, Ahmet Bilici
, et al.
·
Cancers
·
9
PDF
Gemcitabine-associated digital necrosis in metastatic breast cancer
2023
·
Alper Türkel
, Mustafa Özdemir
, et al.
·
Journal of Oncology Pharmacy Practice
·
5
Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular Carcinoma
2025
·
ERGİN AYDEMİR
, FUNDA YILMAZ
, et al.
·
In Vivo
·
4
PDF
Impact of the CPS-EG score as a new prognostic biomarker in triple-negative breast cancer patients who received neoadjuvant chemotherapy
2024
·
İrem Öner
, Alper Türkel
, et al.
·
BMC Cancer
·
4
PDF
The Prognostic Impact of HER2 Status and Survival Outcomes in Metastatic Triple Negative Breast Cancer
2025
·
ALPER TURKEL
, ECE BAYDAR
, et al.
·
In Vivo
·
3
PDF
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025
·
Salih Tunbekici
, Gokhan Sahin
, et al.
·
International Journal of Cancer
·
3
“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
2025
·
Serkan Yaşar
, Ahmet Kadıoğlu
, et al.
·
Medicina
·
3
PDF
Prognostic factors in non-metastatic HER2 ‘low’ and HER2 ‘negative’ breast cancer: single institute experience
2024
·
Alper Türkel
, Mutlu Doğan
, et al.
·
Wiener klinische Wochenschrift
·
3
Predictive value of progesterone receptor in advanced-stage breast cancer patients treated with CDK4/6 inhibitors
2025
·
İrem Öner
, Bediz Kurt İnci
, et al.
·
Anatolian Current Medical Journal
·
2
PDF
Investigation of the prevalence of HER2-ultralow and the effects of HER2 status (HER2-null vs. HER2-ultralow) on survival in HER2-negative early-stage breast cancer
2025
·
Alper Türkel
, Sultan Çiğdem Irkkan
, et al.
·
Clinical & Translational Oncology
·
1
Unilateral facial nerve paralysis following prolonged weekly paclitaxel therapy: a rare case of cranial neurotoxicity with diagnostic challenges
2025
·
Ergin Aydemir
, Alper Türkel
, et al.
·
Journal of Chemotherapy
·
1
Psychometric properties of the Turkish version of the demoralization Scale-II and the association between demoralization and sociodemographic and disease-related factors in Turkish cancer patients
2025
·
Nur Nihal Türkel
, Muhammed Hakan Aksu
, et al.
·
BMC Psychology
·
1
PDF
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2025
·
Neslihan Özyurt
, Ali Alkan
, et al.
·
Scientific Reports
·
1
Evaluation of CDK4/6 inhibitors in first-line in symptomatic and asymptomatic patients with metastatic breast cancer
2024
·
İrem Öner
, Alper Türkel
, et al.
·
Future Oncology
·
1
PDF
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2024
·
Neslihan Özyurt
, Ali Alkan
, et al.
·
Scientific Reports
·
1
Investigation of Clinical Course and Possible Drug Interactions in Patients with Multiple Sclerosis and Breast Cancer
2024
·
Alper Turkel
, Cengiz Karacin
, et al.
·
Journal of College of Physicians And Surgeons Pakistan
·
1
Adjuvant Capecitabine after Neoadjuvant Chemotherapy in Triple Negative Breast Cancer with Lymph Node Metastasis
2023
·
Irem Oner
, Alper Turkel
, et al.
·
Journal of College of Physicians And Surgeons Pakistan
·
1
PDF
Clinical significance of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score as a prognostic indicator in early-stage colon cancer
2026
·
Alper Turkel
, Ergin Aydemir
, et al.
·
Discover Oncology
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
2026
·
Neslihan Özyurt
, Ali Alkan
, et al.
·
Cancers
PDF
PRR11 expression in early ER+/HER2‑low breast cancer: Association with estrogen receptor positivity and exploratory analysis of prognostic significance
2026
·
Alper Turkel
, Mutlu Dogan
, et al.
·
Oncology Letters
PDF
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2026
·
Mustafa Seyyar
, Ali Kalem
, et al.
·
Current Oncology
PDF
Distinct fatigue profiles and psychological mechanisms among breast cancer survivors: A latent profile and mediation analysis
2026
·
Nur Nihal Turkel
, Alper Turkel
, et al.
·
Dusunen Adam The Journal of Psychiatry and Neurological Sciences
PDF
Show more works
View as search
Works count:
40
Citation count:
74
H-index:
5
I10-index:
2
Year
Topic
Type